Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Dubow

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Neurocritical Care|December 18, 2007
Amplification of acute focal ischemic deficit by narcoticsJordan Dubow, Richard A Bernstein
Current Atherosclerosis Reports|June 1, 2011
Impact of hypertension on strokeJordan Dubow, Matthew E Fink
Journal of Neurointerventional Surgery|October 13, 2011
Vertebral artery stenting in a patient with reversed flow in the anterior spinal arteryJordan Dubow, Howard Riina, Athos Patsalides
Clinical Therapeutics|February 26, 2021
Pharmacokinetics of FT218, a Once-Nightly Sodium Oxybate Formulation in Healthy AdultsDavid Seiden, Charles Tyler, Jordan Dubow
Movement Disorders : Official Journal of the Movement Disorder Society|April 5, 2005
Visual system side effects caused by parasympathetic dysfunction after botulinum toxin type B injectionsJordan Dubow, Angela Kim, Jerrold Leikin, et al.
Patient Preference and Adherence|April 15, 2022
Preferences for Attributes of Sodium Oxybate Treatment: A Discrete Choice Experiment in Patients with NarcolepsyJordan Dubow, Alon Y Avidan, Bruce Corser, et al.
Sleep Medicine|October 17, 2022
Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteersRichard Bogan, Michael J Thorpy, John W Winkelman, et al.
NPJ Parkinson'S Disease|July 21, 2017
Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson's diseaseHubert H Fernandez, Weining Z Robieson, Krai Chatamra, et al.
Journal of Parkinson'S Disease|January 16, 2015
Long-term safety and maintenance of efficacy of levodopa-carbidopa intestinal gel: an open-label extension of the double-blind pivotal study in advanced Parkinson's disease patientsJohn T Slevin, Hubert H Fernandez, Cindy Zadikoff, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 20, 2016
Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's diseaseRobert A Hauser, C Warren Olanow, Bruce Dzyngel, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Neurocritical Care|December 18, 2007
Amplification of acute focal ischemic deficit by narcoticsJordan Dubow, Richard A Bernstein
Current Atherosclerosis Reports|June 1, 2011
Impact of hypertension on strokeJordan Dubow, Matthew E Fink
Journal of Neurointerventional Surgery|October 13, 2011
Vertebral artery stenting in a patient with reversed flow in the anterior spinal arteryJordan Dubow, Howard Riina, Athos Patsalides
Clinical Therapeutics|February 26, 2021
Pharmacokinetics of FT218, a Once-Nightly Sodium Oxybate Formulation in Healthy AdultsDavid Seiden, Charles Tyler, Jordan Dubow
Movement Disorders : Official Journal of the Movement Disorder Society|April 5, 2005
Visual system side effects caused by parasympathetic dysfunction after botulinum toxin type B injectionsJordan Dubow, Angela Kim, Jerrold Leikin, et al.
Patient Preference and Adherence|April 15, 2022
Preferences for Attributes of Sodium Oxybate Treatment: A Discrete Choice Experiment in Patients with NarcolepsyJordan Dubow, Alon Y Avidan, Bruce Corser, et al.
Sleep Medicine|October 17, 2022
Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteersRichard Bogan, Michael J Thorpy, John W Winkelman, et al.
NPJ Parkinson'S Disease|July 21, 2017
Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson's diseaseHubert H Fernandez, Weining Z Robieson, Krai Chatamra, et al.
Journal of Parkinson'S Disease|January 16, 2015
Long-term safety and maintenance of efficacy of levodopa-carbidopa intestinal gel: an open-label extension of the double-blind pivotal study in advanced Parkinson's disease patientsJohn T Slevin, Hubert H Fernandez, Cindy Zadikoff, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 20, 2016
Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's diseaseRobert A Hauser, C Warren Olanow, Bruce Dzyngel, et al.
Pageof 3